AI Verdict
PUBM has stronger fundamentals based on our AI analysis.
PVCT vs PUBM Fundamental Comparison
| Metric | PVCT | PUBM |
|---|---|---|
| Revenue | $336,108.0 | $282.9M |
| Net Income | $-5.4M | $-14.5M |
| Net Margin | -1,615.8% | -5.1% |
| ROE | N/A | -5.5% |
| ROA | -778.6% | -2.1% |
| Current Ratio | 0.08x | 1.39x |
| Debt/Equity | N/A | 0.00x |
| EPS | $-0.01 | $-0.31 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
PVCT vs PUBM: Frequently Asked Questions
Is PVCT or PUBM a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), PUBM has stronger fundamentals. PVCT is rated STRONG SELL (95% confidence) while PUBM is rated HOLD (72% confidence). This is not investment advice.
How does PVCT compare to PUBM fundamentally?
PROVECTUS BIOPHARMACEUTICALS, INC. has ROE of N/A vs PubMatic, Inc.'s -5.5%. Net margins are -1,615.8% vs -5.1% respectively.
Which stock pays higher dividends, PVCT or PUBM?
PVCT has a dividend yield of N/A or no dividend while PUBM has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in PVCT or PUBM for long term?
For long-term investing, consider that PVCT has STRONG SELL rating with 95% confidence, while PUBM has HOLD rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about PVCT vs PUBM?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For PVCT vs PUBM, the AI consensus favors PUBM based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.